Status:
RECRUITING
Use of PET-MR in Head and Neck Cancer Patients - Diagnostic and Therapeutic Applications
Lead Sponsor:
Sheffield Teaching Hospitals NHS Foundation Trust
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary research question to be answered in this project is "Are patients with locally-advanced head and neck cancer able to tolerate a PET-MRI scan when they are immobilised in a radiotherapy tre...
Eligibility Criteria
Inclusion
- Aged 18 years or over
- Able to give informed written consent.
- New diagnosis of biopsy-proven head and neck cancer.
- WHO performance status ≤ 2.
- MDT-recommended treatment with radical radiotherapy, with or without concurrent systemic therapy.
- MRI and PET-CT staging scans for diagnosis.
Exclusion
- Known intolerance/sensitivity to 18F-2-deoxyglucose or gadolinium-containing contrast agents.
- Claustrophobia or other contraindications to MRI.
- Unable to pass through a 55 cm hula hoop.
- Female patients that are pregnant or breastfeeding.
- Unable to understand written or spoken English.
- Patients not undergoing radical intent radiotherapy.
- Patients with stage 4 or 5 chronic kidney disease or other biochemical abnormalities e.g. uncontrolled blood glucose levels which can have an impact on PET-MRI imaging or contrast administration.
Key Trial Info
Start Date :
January 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06032663
Start Date
January 2 2024
End Date
October 1 2025
Last Update
April 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Research Centre at Weston Park Hospital
Sheffield, England, United Kingdom, S1O 2SJ